Eloxx director receives options for 8,590 shares
Eloxx Pharmaceuticals director Alan Edmund Walts received a grant of 8,590 stock options to buy common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Eloxx Pharmaceuticals director Alan Edmund Walts received a grant of 8,590 stock options to buy common stock. The options have an exercise price of $11.00 per share and expire on June 8, 2036. They vest in 24 substantially equal monthly installments, becoming fully exercisable on the second anniversary of the grant date, as long as he continues to serve the company. Following this award, he holds 8,590 stock options directly, and the filing does not show any open-market purchases or sales.
Insider Trade Summary
Grant/Award: 8,590 shares
Grant/Award
1 txn
Insider
Walts Alan Edmund
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 8,590 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 8,590 contracts (Direct)
Footnotes (1)
- F1. The stock option will vest in 24 substantially equal monthly installments so that the option will be fully vested and exercisable on the second anniversary of the grant date, subject to the Reporting Person's continuous service to the Issuer through the applicable vesting date.
Key Figures
Options granted: 8,590 options
Exercise price: $11.00 per share
Expiration date: June 8, 2036
+3 more
6 metrics
Options granted
8,590 options
Stock Option (Right to Buy) granted to director on June 8, 2026
Exercise price
$11.00 per share
Conversion or exercise price of granted stock options
Expiration date
June 8, 2036
Options expire on this date
Underlying shares
8,590 shares
Common stock underlying the stock options
Total options after grant
8,590 options
Total derivative securities held following transaction
Vesting schedule
24 monthly installments
Options fully vest by second anniversary of grant date
Key Terms
Stock Option (Right to Buy), exercise price, expiration date, Common Stock, +2 more
6 terms
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
exercise price financial
"conversion_or_exercise_price: 11.0000"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: 2036-06-08T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
Common Stock financial
"underlying_security_title: Common Stock"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
Grant, award, or other acquisition financial
"transaction_code_description: Grant, award, or other acquisition"
vesting financial
"The stock option will vest in 24 substantially equal monthly installments"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Eloxx Pharmaceuticals (ELOX) disclose in this Form 4 filing?
Eloxx Pharmaceuticals disclosed that director Alan Edmund Walts received a grant of 8,590 stock options. These options give him the right to buy common shares at $11.00 each, expiring June 8, 2036, with vesting over two years.
How many stock options did Alan Edmund Walts receive from Eloxx Pharmaceuticals (ELOX)?
Alan Edmund Walts received 8,590 stock options as reported in the Form 4. Each option represents the right to purchase one share of Eloxx common stock, subject to vesting conditions and the $11.00 exercise price.
What is the exercise price and expiration date of the ELOX options granted to Alan Walts?
The options granted to Alan Walts have an exercise price of $11.00 per share and expire on June 8, 2036. This means he can buy Eloxx common shares at $11.00 any time after vesting until that expiration date.
How do the Eloxx Pharmaceuticals (ELOX) options granted to Alan Walts vest?
The options vest in 24 substantially equal monthly installments starting from the grant date. They become fully vested and exercisable on the second anniversary of the grant, provided Alan Walts maintains continuous service with Eloxx through each vesting date.
How many Eloxx Pharmaceuticals options does Alan Walts hold after this grant?
After the reported grant, Alan Walts holds 8,590 stock options directly, as shown by the total shares following the transaction. These options relate to Eloxx common stock and are subject to the stated vesting and expiration terms.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates